# Greenland Mines Ltd: financial statements, quarterly

GRML · Nasdaq · CIK 1907223 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grml.md) · [Financials](/companies/grml/financials.md) · [Filings](/companies/grml/filings.md) · [Insiders](/companies/grml/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grml/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | [0.0](/filings/0001213900-24-100218.md) | [0.0 d](/filings/0001213900-25-026372.md) | [0.0](/filings/0001213900-25-043529.md) | [0.0](/filings/0001213900-24-070786.md) | [0.0](/filings/0001213900-24-100218.md) | [0.0 d](/filings/0001213900-25-026372.md) | [0.0](/filings/0001213900-25-043529.md) | [0.2](/filings/0001213900-26-090821.md) | [0.3](/filings/0001213900-25-109920.md) | [0.1 d](/filings/0001213900-26-090213.md) | [0.3](/filings/0001213900-26-090289.md) | [0.4](/filings/0001213900-26-090821.md) |
| Operating income | $m | [(0.1)](/filings/0001213900-24-100218.md) | [(0.1) d](/filings/0001213900-25-026372.md) | [(0.7)](/filings/0001213900-25-043529.md) | [(0.4)](/filings/0001213900-25-077684.md) | [(2.9)](/filings/0001213900-25-109920.md) | [(1.9) d](/filings/0001213900-26-090213.md) | [(1.6)](/filings/0001213900-26-090289.md) | [(1.9)](/filings/0001213900-26-090821.md) | [(1.9)](/filings/0001213900-25-109920.md) | [(1.8) d](/filings/0001213900-26-090213.md) | [(9.5)](/filings/0001213900-26-090289.md) | [(5.5)](/filings/0001213900-26-090821.md) |
| Interest expense | $m | [0.0](/filings/0001213900-24-100218.md) | [0.0 d](/filings/0001213900-25-026372.md) | not reported | [0.0](/filings/0001213900-25-077684.md) | [0.0](/filings/0001213900-25-109920.md) | [0.3 d](/filings/0001213900-26-090213.md) | [0.6](/filings/0001213900-26-090289.md) | [1.8](/filings/0001213900-26-090821.md) | [1.2](/filings/0001213900-25-109920.md) | [(1.2) d](/filings/0001213900-26-090213.md) | [0.0](/filings/0001213900-26-090289.md) | [0.0](/filings/0001213900-26-090821.md) |
| Income tax | $m | [0.1](/filings/0001213900-23-088042.md) | [0.1 d](/filings/0001213900-24-033573.md) | [0.0](/filings/0001213900-24-046038.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(0.1)](/filings/0001213900-24-100218.md) | [(0.1)](/filings/0001213900-24-100218.md) | [(0.7)](/filings/0001213900-25-109920.md) | [(0.5)](/filings/0001213900-25-109920.md) | [(3.0)](/filings/0001213900-25-109920.md) | [(2.1) d](/filings/0001213900-26-090213.md) | [(2.2)](/filings/0001213900-26-090821.md) | [(4.1)](/filings/0001213900-26-090821.md) | [(2.9)](/filings/0001213900-25-109920.md) | [(1.3) d](/filings/0001213900-26-090213.md) | [(13.9)](/filings/0001213900-26-090821.md) | [(3.7)](/filings/0001213900-26-090821.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001213900-24-100218.md) | not reported | [(0.04)](/filings/0001213900-25-043529.md) | [(0.03)](/filings/0001213900-25-077684.md) | [(0.18)](/filings/0001213900-25-109920.md) | not reported | [(0.08)](/filings/0001213900-26-090289.md) | [(0.12)](/filings/0001213900-26-090821.md) | [(0.05)](/filings/0001213900-25-109920.md) | not reported | [(0.15)](/filings/0001213900-26-090289.md) | [(0.03)](/filings/0001213900-26-090821.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001213900-24-100218.md) | not reported | [(0.04)](/filings/0001213900-25-043529.md) | [(0.03)](/filings/0001213900-25-077684.md) | [(0.18)](/filings/0001213900-25-109920.md) | not reported | [(0.08)](/filings/0001213900-26-090289.md) | [(0.12)](/filings/0001213900-26-090821.md) | [(0.05)](/filings/0001213900-25-109920.md) | not reported | [(0.15)](/filings/0001213900-26-090289.md) | [(0.03)](/filings/0001213900-26-090821.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-03-04) | Q1 FY2024 (2024-03-31) | period not labelled (2024-04-22) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001213900-25-026372.md) | [0.0](/filings/0001213900-24-046038.md) | [1.0](/filings/0001213900-24-070786.md) | [0.8](/filings/0001213900-24-070786.md) | [0.1](/filings/0001213900-24-100218.md) | [0.1](/filings/0001213900-26-090213.md) | [0.6](/filings/0001213900-25-043529.md) | [8.4](/filings/0001213900-25-077684.md) | [7.3](/filings/0001213900-25-109920.md) | [7.2](/filings/0001213900-26-090289.md) | [10.0](/filings/0001213900-26-090289.md) | [9.3](/filings/0001213900-26-090821.md) |
| Current assets | $m | not reported | [0.0](/filings/0001213900-24-046038.md) | not reported | [1.0](/filings/0001213900-24-070786.md) | [0.2](/filings/0001213900-24-100218.md) | [0.2](/filings/0001213900-26-090213.md) | [0.7](/filings/0001213900-25-043529.md) | [8.5](/filings/0001213900-25-077684.md) | [7.8](/filings/0001213900-25-109920.md) | [7.3](/filings/0001213900-26-090821.md) | [10.9](/filings/0001213900-26-090289.md) | [12.2](/filings/0001213900-26-090821.md) |
| Total assets | $m | not reported | [19.6](/filings/0001213900-24-046038.md) | not reported | [3.3](/filings/0001213900-24-070786.md) | [2.5](/filings/0001213900-24-100218.md) | [2.5](/filings/0001213900-26-090213.md) | [3.0](/filings/0001213900-25-043529.md) | [10.8](/filings/0001213900-25-077684.md) | [10.1](/filings/0001213900-25-109920.md) | [9.6](/filings/0001213900-26-090821.md) | [59.7](/filings/0001213900-26-090289.md) | [65.0](/filings/0001213900-26-090821.md) |
| Current liabilities | $m | not reported | [2.6](/filings/0001213900-24-046038.md) | not reported | [0.9](/filings/0001213900-24-070786.md) | [1.0](/filings/0001213900-24-100218.md) | [1.2](/filings/0001213900-26-090213.md) | [2.3](/filings/0001213900-25-043529.md) | [0.1](/filings/0001213900-25-077684.md) | [0.1](/filings/0001213900-25-109920.md) | [0.1](/filings/0001213900-26-090821.md) | [0.6](/filings/0001213900-26-090289.md) | [1.2](/filings/0001213900-26-090821.md) |
| Total liabilities | $m | not reported | [8.5](/filings/0001213900-24-046038.md) | not reported | [4.9](/filings/0001213900-24-070786.md) | [1.0](/filings/0001213900-24-100218.md) | [1.3](/filings/0001213900-26-090213.md) | [2.3](/filings/0001213900-25-043529.md) | [0.2](/filings/0001213900-25-077684.md) | [0.1](/filings/0001213900-25-109920.md) | [0.1](/filings/0001213900-26-090821.md) | [8.3](/filings/0001213900-26-090289.md) | [7.1](/filings/0001213900-26-090821.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | [0.4](/filings/0001213900-25-109920.md) | not reported | [(1.6)](/filings/0001213900-25-109920.md) | [1.5](/filings/0001213900-25-109920.md) | [1.2](/filings/0001213900-26-090821.md) | [0.6](/filings/0001213900-26-090821.md) | [10.7](/filings/0001213900-26-090821.md) | [9.9](/filings/0001213900-25-109920.md) | [9.5](/filings/0001213900-26-090821.md) | [51.5](/filings/0001213900-26-090821.md) | [57.9](/filings/0001213900-26-090821.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [18.0 d](/filings/0001213900-24-100218.md) | [(200) d](/filings/0001213900-25-026372.md) | [(22.0)](/filings/0001213900-25-043529.md) | [(907) d](/filings/0001213900-25-077684.md) | [(1,073) d](/filings/0001213900-25-109920.md) | [(944) d](/filings/0001213900-26-090213.md) | [(1,554)](/filings/0001213900-26-090289.md) | [(1,937) d](/filings/0001213900-26-090821.md) | [(1,119) d](/filings/0001213900-25-109920.md) | [(1,279) d](/filings/0001213900-26-090213.md) | [(4,971)](/filings/0001213900-26-090289.md) | [(6,854) d](/filings/0001213900-26-090821.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.5](/filings/0001213900-22-027170.md) | [15.1](/filings/0001213900-24-100218.md) | [15.1](/filings/0001213900-25-043529.md) | [15.7](/filings/0001213900-25-077684.md) | [16.7](/filings/0001213900-25-109920.md) | [27.5](/filings/0001213900-26-090289.md) | [34.0](/filings/0001213900-26-090821.md) | [59.4](/filings/0001213900-25-109920.md) | [93.7](/filings/0001213900-26-090289.md) | [127](/filings/0001213900-26-090821.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 158,850,637 at 2026-08-17, from the cover of the [10-Q filed 2026-08-17](/filings/0001213900-26-090821.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.